.::INMEGEN::. ·

Publicacion

Titulo:	Role of Smac/DIABLO in cancer progression
Autores:	MARTINEZ-RUIZ G VILMA ARACELI MALDONADO LAGUNAS GISELA CEBALLOS CANCINO JUAN PABLO REYES GRAJEDA JORGE MELÉNDEZ ZAJGLA
Tipo de Licencia:	http://creativecommons.org/licenses/by/4.0
Fecha de Publicación:	26 de Septiembre de 2008
Resumen:	Second mitochondria-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI (Smac/DIABLO) is a proapoptogenic mitochondrial protein that is released to the cytosol in response to diverse apoptotic stimuli, including commonly used chemotherapeutic drugs. In the cytosol, Smac/DIABLO interacts and antagonizes inhibitors of apoptosis proteins (IAPs), thus allowing the activation of caspases and apoptosis. This activity has prompted the synthesis of peptidomimetics that could potentially be used in cancer therapy. For these reasons, several authors have analyzed the expression levels of Smac/DIABLO in samples of patients from different tumors. Although dissimilar results have been found, a tissue-specific role of this protein emerges from the data. The objective of this review is to present the current knowledge of the Smac/DIABLO role in cancer and its possible use as a marker or therapeutic target for drug design.
Editorial:	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Idioma:	Ingles
Palabras Clave:	Animals Apoptosis Caspases/metabolism Disease Progression Humans Inhibitor of Apoptosis Proteins/antagonists & inhibitors/genetics/metabolism Intracellular Signaling Peptides and Proteins/metabolism Mitochondrial Proteins/metabolism Models Biological Neoplasms/*metabolism
URL:	https://repositorio.inmegen.gob.mx/record/178

Ficheros en este ítem:

Archivo	Formato
Role_of_Smac_DIABLO_in_cancer_progression_1.pdf	PDF	Ver/Descargar